InsiderClue
Stocks · Health care · Pharmaceutical Preparations

CorMedix Inc.

CRMD Clue Score79
United States Fiscal year ends December CIK 0001410098
$7.38 +0.82% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $7.38 +51.23% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 12 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2016Revenue0.2Operating income−24.8Net income−24.6Fiscal year 2017Revenue0.3 +47.0%Operating income−32.9Net income−33.0Fiscal year 2018Revenue0.4 +30.5%Operating income−26.9Net income−26.8Fiscal year 2019Revenue0.3 −34.1%Operating income−21.0Net income−16.4Fiscal year 2020Revenue0.2 −15.5%Operating income−27.2Net income−22.0Fiscal year 2021Revenue0.2 −20.2%Operating income−29.4Net income−28.2EPS, diluted−0.75Fiscal year 2022Revenue0.1 −65.7%Operating income−30.6Net income−29.7EPS, diluted−0.74Fiscal year 2023Operating income−49.0Net income−46.3EPS, diluted−0.91Fiscal year 2024Revenue43.5Operating income−22.4Net income−17.9EPS, diluted−0.30Fiscal year 2025Revenue311.7 +617.0%Operating income150.1Net income163.1EPS, diluted2.04
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 0.2 0.3 0.4 0.3 0.2 0.2 0.1 n/a 43.5 311.7
Growth +47.0% +30.5% −34.1% −15.5% −20.2% −65.7% +617.0%
Operating income −24.8 −32.9 −26.9 −21.0 −27.2 −29.4 −30.6 −49.0 −22.4 150.1
Net income −24.6 −33.0 −26.8 −16.4 −22.0 −28.2 −29.7 −46.3 −17.9 163.1
Growth
EPS, diluted n/a n/a n/a n/a n/a −0.75 −0.74 −0.91 −0.30 2.04

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Gross marginOperating marginNet margin
Fiscal year 2016Gross margin−63.6%Operating margin−11,048.8%Net margin−10,996.5%Free cash flow margin−9,961.5%Fiscal year 2017Gross margin65.1%Operating margin−9,997.4%Net margin−10,023.4%Free cash flow margin−8,726.6%Fiscal year 2018Gross margin7.7%Operating margin−6,250.4%Net margin−6,242.4%Free cash flow margin−5,525.7%Fiscal year 2019Gross margin−31.8%Operating margin−7,416.3%Net margin−5,801.3%Free cash flow margin−5,326.7%Fiscal year 2020Gross margin14.4%Operating margin−11,378.4%Net margin−9,207.7%Free cash flow margin−9,229.7%Fiscal year 2021Gross margin22.0%Operating margin−15,417.5%Net margin−14,774.7%Free cash flow margin−11,826.2%Fiscal year 2022Gross margin94.3%Operating margin−46,819.9%Net margin−45,409.9%Free cash flow margin−37,573.5%Fiscal year 2023Fiscal year 2024Gross margin92.7%Operating margin−51.4%Net margin−41.2%Free cash flow margin−116.7%Fiscal year 2025Gross margin88.5%Operating margin48.2%Net margin52.3%Free cash flow margin55.4%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Gross margin −63.6% 65.1% 7.7% −31.8% 14.4% 22.0% 94.3% n/a 92.7% 88.5%
Operating margin −11,048.8% −9,997.4% −6,250.4% −7,416.3% −11,378.4% −15,417.5% −46,819.9% n/a −51.4% 48.2%
Net margin −10,996.5% −10,023.4% −6,242.4% −5,801.3% −9,207.7% −14,774.7% −45,409.9% n/a −41.2% 52.3%
Free cash flow margin −9,961.5% −8,726.6% −5,525.7% −5,326.7% −9,229.7% −11,826.2% −37,573.5% n/a −116.7% 55.4%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2016Operating cash flow−22.3Capital expenditure−0.1Free cash flow−22.3Fiscal year 2017Operating cash flow−28.6Capital expenditure−0.2Free cash flow−28.7Fiscal year 2018Operating cash flow−23.7Capital expenditure−0.0Free cash flow−23.7Fiscal year 2019Operating cash flow−15.1Capital expenditure−0.0Free cash flow−15.1Fiscal year 2020Operating cash flow−22.0Capital expenditure−0.1Free cash flow−22.1Fiscal year 2021Operating cash flow−21.2Capital expenditure−1.4Free cash flow−22.6Fiscal year 2022Operating cash flow−24.4Capital expenditure−0.2Free cash flow−24.6Fiscal year 2023Operating cash flow−38.4Capital expenditure−0.3Free cash flow−38.7Fiscal year 2024Operating cash flow−50.6Capital expenditure−0.1Free cash flow−50.7Fiscal year 2025Operating cash flow175.0Capital expenditure−2.3Free cash flow172.8
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −22.3 −28.6 −23.7 −15.1 −22.0 −21.2 −24.4 −38.4 −50.6 175.0
Capital expenditure −0.1 −0.2 −0.0 −0.0 −0.1 −1.4 −0.2 −0.3 −0.1 −2.3
Free cash flow −22.3 −28.7 −23.7 −15.1 −22.1 −22.6 −24.6 −38.7 −50.7 172.8
Growth

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash
Fiscal year 2016Cash8.1Shareholders’ equity17.8Fiscal year 2017Cash10.4Shareholders’ equity7.2Fiscal year 2018Cash17.6Shareholders’ equity4.9Fiscal year 2019Cash16.4Shareholders’ equity23.6Fiscal year 2020Cash41.9Shareholders’ equity44.2Fiscal year 2021Cash53.3Shareholders’ equity62.8Fiscal year 2022Cash43.1Shareholders’ equity55.1Fiscal year 2023Cash43.6Shareholders’ equity70.1Fiscal year 2024Cash40.7Shareholders’ equity84.7Fiscal year 2025Cash144.8Shareholders’ equity405.3
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 8.1 10.4 17.6 16.4 41.9 53.3 43.1 43.6 40.7 144.8
Shareholders’ equity 17.8 7.2 4.9 23.6 44.2 62.8 55.1 70.1 84.7 405.3

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2016 31 Dec 2016 FY2017 31 Dec 2017 FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024† 31 Dec 2024 FY2025 31 Dec 2025
Revenue and profit
0.2 0.3 0.4 0.3 0.2 0.2 0.1 n/a 43.5 311.7
Growth +47.0% +30.5% −34.1% −15.5% −20.2% −65.7% +617.0%
0.4 0.1 0.4 0.4 0.2 0.1 0.0 n/a 3.0 22.1
−0.1 0.2 0.0 −0.1 0.0 0.0 0.1 n/a 40.3 275.7
Growth −84.6% −372.5% +22.1% +46.8% +584.5%
15.7 24.5 18.8 11.1 13.4 13.1 10.7 13.2 3.9 19.3
8.9 8.7 8.1 9.9 13.9 16.3 20.0 35.8 30.0 68.2
−24.8 −32.9 −26.9 −21.0 −27.2 −29.4 −30.6 −49.0 −22.4 150.1
Growth
−24.6 −33.0 −26.8 −21.5 −27.2 −29.5 −30.3 −46.3 −19.3 150.0
n/a n/a n/a −5.1 −5.2 −1.3 −0.6 n/a −1.4 −13.0
−24.6 −33.0 −26.8 −16.4 −22.0 −28.2 −29.7 −46.3 −17.9 163.1
Growth
Per share
n/a n/a n/a n/a n/a −0.75 −0.74 −0.91 −0.30 2.25
n/a n/a n/a n/a n/a −0.75 −0.74 −0.91 −0.30 2.04
Growth
n/a n/a n/a n/a n/a 37.7 40.3 50.9 0.1 0.1
n/a n/a n/a n/a n/a 37.7 40.3 50.9 0.1 0.1
Growth +6.9% +26.4% −99.9% +36.4%

† The diluted share count jumps at 2024, so per-share figures either side of that column are not comparable. Usually a split, but the break lands on the restatement boundary rather than on the split date, because every column is that period’s latest filing.

Five years in brief

Worked out from the figures above, not from a press release
  • Revenue grew 305.8% a year over five years.
  • Operating margin is up 7,464.5 points on five years ago, at 48.2%.
  • A net loss in 9 of 10 years on file.